LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3637 | 3769 | 0.9650 | 0.9507 |
BT-20 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3105 | 3769 | 0.8237 | 0.7513 |
BT-20 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3113 | 3769 | 0.8260 | 0.7546 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 778 | 3769 | 0.2064 | -0.1195 |
BT-20 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3239 | 3769 | 0.8593 | 0.8016 |
BT-20 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3006 | 3769 | 0.7976 | 0.7145 |
BT-20 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3850 | 3769 | 1.0215 | 1.0304 |
BT-20 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2905 | 3769 | 0.7707 | 0.6765 |
BT-20 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3748 | 3769 | 0.9944 | 0.9921 |
BT-20 | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2987 | 3769 | 0.7926 | 0.7074 |
BT-20 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2963 | 3769 | 0.7862 | 0.6984 |
BT-20 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2916 | 3769 | 0.7736 | 0.6806 |
BT-20 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3807 | 3769 | 1.0099 | 1.0140 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3950 | 3769 | 1.0481 | 1.0678 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3436 | 3769 | 0.9116 | 0.8753 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1097 | 1459 | 3769 | 0.3872 | 0.1356 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1404 | 3769 | 0.3725 | 0.1148 |
BT-20 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3292 | 3769 | 0.8734 | 0.8214 |
BT-20 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 2893 | 3769 | 0.7676 | 0.6721 |
BT-20 | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3963 | 3769 | 1.0515 | 1.0726 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3560 | 3769 | 0.9444 | 0.9216 |
BT-20 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 4119 | 3769 | 1.0929 | 1.1310 |
BT-20 | Dactolisib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 1392 | 3769 | 0.3693 | 0.1103 |
BT-20 | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3786 | 3769 | 1.0045 | 1.0064 |
BT-20 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2420 | 3769 | 0.6421 | 0.4951 |